Lithium Ion

Lithium Ion

SCHEMBL808460

CC(C)(C)O[Al](OC(C)(C)C)OC(C)(C)C.[2H-].[Li+]

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL11332262 0.92 TSHR (0.31) TSHRTDP1ALDH1A1
Lithium Ion SCHEMBL589 0.92 TSHR (0.31) TSHRTDP1ALDH1A1
Lithium Ion SCHEMBL11332267 0.92 TSHR (0.31) TSHRTDP1ALDH1A1
SCHEMBL107947 0.92 ALDH1A1 (0.36) TSHRTDP1ALDH1A1
Lithium Ion SCHEMBL14812375 0.89
Lithium Ion SCHEMBL2059893 0.89
Lithium Ion SCHEMBL9293254 0.89
Lithium Ion SCHEMBL9293243 0.89
SCHEMBL1939142 0.88 ALDH1A1 (0.33) TSHRTDP1ALDH1A1
SCHEMBL590 0.88 ALDH1A1 (0.33) TSHRTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1457482-B9 Stable isotope-labeled amino acid, method of integrating the same into target protein, method of NMR structural analysis of protein JAPAN SCIENCE & TECH AGENCY (JP) 2012-10-24 EP disclosed
EP-1457482-B1 Stable isotope-labeled amino acid, method of integrating the same into target protein, method of NMR structural analysis of protein JAPAN SCIENCE & TECH AGENCY (JP) 2012-01-18 EP disclosed
US-7022310-B2 Stable isotope-labeled amino acid and method for incorporating same into target protein AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2006-04-04 US disclosed
US-20050084452-A1 Stable isotope-labeled amino acid and method for incorporating same into target protein JAPANESE SCIENCE AND TECHNOLOGY AGENCY 2005-04-21 US disclosed
EP-1457482-A1 STABLE ISOTOPE-LABELED AMINO ACID, METHOD OF INTEGRATING THE SAME INTO TARGET PROTEIN, METHOD OF NMR STRUCTURAL ANALYSIS OF PROTEIN AND PROCESS FOR PRODUCING SITE-SELECTIVE STABLE ISOTOPE-LABELED FUMARIC ACID AND TARTARIC ACID Japan Science and Technology Agency (JP) 2004-09-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050084452-A1 Stable isotope-labeled amino acid and method for incorporating same into target protein GEMIN5, ATIC, AIP TSHR 2848/4885TDP1 2575/4885ALDH1A1 4079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.